The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Novozhilova E.N.

Moscow City Cancer Hospital Sixty-Two

Shchupak M.Iu.

Moscow oncology hospital №62

Olshanskaya O.V.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Evgrafov A.A.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Glavatsky S.V.

Moscow City Cancer Hospital Sixty-Two

Calcium metabolism and the clinical manifestations of primary hyperparathyroidism

Authors:

Novozhilova E.N., Shchupak M.Iu., Olshanskaya O.V., Evgrafov A.A., Glavatsky S.V.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2016;5(5): 38‑41

Read: 16547 times


To cite this article:

Novozhilova EN, Shchupak MIu, Olshanskaya OV, Evgrafov AA, Glavatsky SV. Calcium metabolism and the clinical manifestations of primary hyperparathyroidism. P.A. Herzen Journal of Oncology. 2016;5(5):38‑41. (In Russ.)
https://doi.org/10.17116/onkolog20165538-41

Recommended articles:
Features of differential diagnosis of onco­logical pathology at the outpatient stage. Russian Journal of Preventive Medi­cine. 2025;(2):93-95
Economic issues of medi­cal care for hype­rparathyroidism. Part 1. Primary hype­rparathyroidism. Medi­cal Technologies. Asse­ssment and Choice. 2025;(1):51-61
Modern approaches to cystic lung diseases diagnosis. Journal of Respiratory Medi­cine. 2025;(1):30-37
5q spinal muscular atro­phy in adults. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):142-147
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
OCT patterns as a source of errors in the diagnosis of intraocular tumors. Russian Annals of Ophthalmology. 2025;(3):63-70
MR imaging of cyto­toxic lesion of the corpus callosum during pneumonia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):140-144

References:

  1. Hedback G, Oden A. Deаth risk factor analysis in primary hyperparathyreoidism. Eur J Clin Invest. 1998;28(12):1011-1018. doi: 10.1046/j.1365-2362.1998.00387.x
  2. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005;11(1):49-54. doi: 10.4158/ep.11.1.49
  3. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe J Bone Miner Res. 2002;17(Suppl.2):N18-N23.
  4. McDermott MT, ed. Endocrine secrets. 5th ed. Philadelphia: Elsevier; 2009.
  5. Duncan E. How to treat: calcium and phosphate disorders — Part 2. Australian Doctor. 2008-04-17;26-32.
  6. Nilsson IL, Yin L, Lundgren E, Rastad J, Ekbom A. Clinical presentation of primary hyperparathyroidism in Europe-cohort analysis on mortality from non malignant causes. J Bone Miner Res. 2002;17(Suppl.2):N68-N74.
  7. DeLellis RA, Mazzaglia P, Mangray S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med. 2008;132(8):1251-1262. doi: 10.1043/1543-2165(2008)132[1251:PHACP]2.0.CO;2
  8. Dedov I, Petrakova V, eds. Manual Endocrinology [Rukovodstvo po jendokrinologii]. Moscow: Universum pablishing; 2006. (In Russ.)
  9. Flynn RW, Macdonald TM, Jung RT, Morris AD, Leese GP. Mortality and outcomes in patients treated thyroid dysfunction. J Clin Endocrinol Metab. 2006;91(6):2159-2164. doi: 10.1210/jc.2005-1833
  10. Jorde R, Bønaa KH, Sundsfjord J. Primary hyperparathyroidism detected in health screening. J Clin Epidemiol. 2000;53(11):1164-1169. doi: 10.1016/s0895-4356(00)00239-0

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.